Somnus Scientific develops a suite of products to measure blood propofol concentration in real-time and without blood sampling.
Somnus Scientific has raised $830K in total funding. The most recent round was Seed. The last funding was announced in July 2021.
Somnus Scientific's investors include Utilico Emerging Markets.
Somnus Scientific is headquartered in London, United Kingdom.
Somnus Scientific develops a suite of products to measure blood propofol concentration in real-time and without blood sampling.
Somnus Scientific is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Somnus Scientific — Funding & Investors." VCBacked, July 2, 2021, https://www.vcbacked.co/company/somnus-scientific. Accessed November 13, 2026.
VCBacked. (2021). Somnus Scientific — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/somnus-scientific
{{cite web |title=Somnus Scientific — Funding & Investors |url=https://www.vcbacked.co/company/somnus-scientific |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Somnus Scientific? Request a listing update